Article Text

Download PDFPDF
Little evidence that cholinesterase inhibitors prevent progression of mild cognitive impairment to dementia, but they are associated with adverse effects

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Sources of funding: Alzheimer Scotland, BBSRC, EPSRC, ESRC and MRC, UK.


  • Competing interests None.

  • Correction notice This article has been corrected since it was published Online First. The author name has been corrected from ‘Carlos Rojas-Fernandez PharmD’ to ‘Carlos H Rojas-Fernandez’.